Autopsy report · NCT05367336

Platelet Reactivity With Fentanyl, Morphine, or no Narcotic

“The study was halted prematurely due to difficulties in recruiting a sufficient number of participants. Despite efforts to enroll eligible individuals, the recruitment goals were not met, making it infeasible to continue the study as planned.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 2 years 6 months before it stopped.
• 21 participants enrolled.
• Results were posted on the registry 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Corewell Health South

Sponsor type

University, hospital or other

Conditions

Fentanyl; Platelet Reactivity

Interventions

Morphine; Fentanyl

Participants

21

Sites

1

Countries

United States

Trials that died the same way

• Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy
  “The study was prematurely halted primarily due to low patient accrual. Despite efforts to optimize recruitment, the enrollment rate remained insufficient to meet the predefined targets, and continuation was deemed unfeasible” (84% match in meaning)
• The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder
  “This study was halted prior to accumulating the full number of participants due to difficulty in recruiting study subjects.” (82% match in meaning)
• Ultrasound and Endometrial Hyperplasia
  “enrollment of participants has halted prematurely; difficulty with recruitment” (81% match in meaning)
• High Cut Off Dialysis in Systemic Inflammatory Response Syndrome Patients After Cardiac Surgery
  “Study halted prematurely, prior to enrollment of first patient, due to recruiting problems.” (80% match in meaning)
• MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV
  “The recruitment was stopped prematurely by the sponsor in accordance with the principal investigator because of the difficulties to recruit patients and to achieve the planned numbers of patients within a reasonable time frame.” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.